Key Highlights
- Shares closed at $29.20 at last closing, down 1.82%.
- Second-quarter 2026 record Revenue was about $83.7 million, up roughly 12.5% and beating estimates, with Net Income up around 24%.
- Adjusted EBITDA rose around 17%, driven by subscription growth that was mostly organic with some contribution from acquisitions.
- HealthStream updated its full-year guidance and continued to pay a Dividend and repurchase shares.
HealthStream (NASDAQ:HSTM) is a healthcare-technology company that provides workforce-focused software-as-a-service, including learning, credentialing, competency, and scheduling solutions for hospitals and health systems. Shares closed at $29.20 at last closing, down 1.82%.
Its results depend on subscription revenue and its growth, customer adoption, and its margins and adjusted EBITDA, so it is exposed to healthcare-workforce technology spending.
Latest Developments
In its second-quarter 2026 results, HealthStream reported record revenue of about $83.7 million, up roughly 12.5% and beating estimates, with net income up around 24%, Earnings Per Share of about $0.23, and adjusted EBITDA up around 17%, driven by subscription growth that was mostly organic. Today's decline appears to reflect broader market or sector sentiment rather than any change to that steady operating performance. Investors should confirm the latest subscription revenue growth and adjusted EBITDA margins directly from SEC filings.
Financial and Business Position
HealthStream's Investment case rests on its healthcare-workforce software franchise, its subscription revenue growth, and its margins and adjusted EBITDA, balanced against the pace of healthcare-technology spending and competition. Investors should watch revenue and subscription growth, and adjusted EBITDA margins.
Stock-Market Context
HSTM shares closed at $29.20 at last closing, down 1.82%. The stock trades as a steady, profitable healthcare-software company whose valuation reflects its Recurring Revenue and margins, and the record results argue this is durable, profitable compounding rather than an imminent inflection point that today's decline would reflect.
What Investors Should Watch
Watch revenue and subscription growth, net income and earnings, adjusted EBITDA and margins, and guidance. Continued subscription revenue growth combined with Margin expansion would support the fundamentals regardless of near-term price swings.






Please wait processing your request...